David E. Fisher
15Patents
2h-index
28Co-inventors
54Inventor score
Filing activity: Jan 13, 1999 → Mar 27, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10954242B2 | Bicyclic urea kinase inhibitors and uses thereof | Human Necessities | 7 | Active |
| US11725011B2 | Bicyclic urea kinase inhibitors and uses thereof | Human Necessities | 2 | Active |
| US9745261B2 | Inhibitors of the MITF molecular pathway | Chemistry; Metallurgy | 2 | Active |
| US7338767B1 | Use of microphthalmia for diagnosis, prognosis and/or treatment of melanoma | Physics | 1 | Expired |
| US10653355B2 | Non-invasive visualization and quantification of natural pigments | Physics | 0 | Active |
| US11433068B2 | Treatment of cancers having alterations within the SWI/SNF chromatin remodeling complex | Chemistry; Metallurgy | 0 | Active |
| US11878019B2 | Uses of pyrimidopyrimidinones as SIK inhibitors | Human Necessities | 0 | Active |
| US11045520B2 | Compositions and methods for topical delivery of pharmaceutical agents | Human Necessities | 0 | Active |
| US9883996B2 | Methods and compositions for enhancing skin pigmentation | Human Necessities | 0 | Active |
| US12398145B2 | Bicyclic urea kinase inhibitors and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US7776520B2 | Use of microphthalmia for diagnosis, prognosis and/or treatment of melanoma | Physics | 0 | Expired |
| US7645589B2 | Use of microphthalmia for diagnosis, prognosis and/or treatment of melanoma | Physics | 0 | Active |
| US11827591B2 | Compositions and methods of preparation thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US11285158B2 | Uses of pyrimidopyrimidinones as SIK inhibitors | Human Necessities | 0 | Active |
| US9937161B2 | Combinatorial compositions and methods for treatment of melanoma | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.